10-79612410-C-G
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_005411.5(SFTPA1):āc.271C>Gā(p.Pro91Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00919 in 1,613,396 control chromosomes in the GnomAD database, including 94 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_005411.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SFTPA1 | NM_005411.5 | c.271C>G | p.Pro91Ala | missense_variant | 4/6 | ENST00000398636.8 | NP_005402.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SFTPA1 | ENST00000398636.8 | c.271C>G | p.Pro91Ala | missense_variant | 4/6 | 1 | NM_005411.5 | ENSP00000381633 | P1 | |
SFTPA1 | ENST00000419470.6 | c.316C>G | p.Pro106Ala | missense_variant | 4/6 | 1 | ENSP00000397082 | |||
SFTPA1 | ENST00000428376.6 | c.271C>G | p.Pro91Ala | missense_variant | 3/5 | 1 | ENSP00000411102 | P1 | ||
SFTPA1 | ENST00000429958.5 | c.271C>G | p.Pro91Ala | missense_variant | 3/5 | 1 | ENSP00000395527 |
Frequencies
GnomAD3 genomes AF: 0.00867 AC: 1317AN: 151876Hom.: 7 Cov.: 32
GnomAD3 exomes AF: 0.00704 AC: 1769AN: 251330Hom.: 9 AF XY: 0.00717 AC XY: 974AN XY: 135838
GnomAD4 exome AF: 0.00924 AC: 13506AN: 1461402Hom.: 87 Cov.: 34 AF XY: 0.00924 AC XY: 6719AN XY: 727030
GnomAD4 genome AF: 0.00867 AC: 1318AN: 151994Hom.: 7 Cov.: 32 AF XY: 0.00797 AC XY: 592AN XY: 74304
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2024 | SFTPA1: BS1, BS2 - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 21, 2013 | Pro106Ala in exon 4 of SFTPA1: This variant is not expected to have clinical sig nificance because it has been identified in 1.4% (61/4406) of African American c hromosomes from a broad population by the NHLBI Exome Sequencing Project (http:/ /evs.gs.washington.edu/EVS; dbSNP rs1136452). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at